首页> 外文OA文献 >Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?

【2h】

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?

机译：胰岛素/胰高血糖素类肽-1受体激动剂组合治疗用于治疗2型糖尿病：是两种剂量优于一个剂吗？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Vanita R. Aroda; Joseph R. Arulandu; Anthony J. Cannon;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy [J] . Shubrook Jay H. The Journal of family practice . 2018,第8Suppla期

机译：2型糖尿病进展：专注于基础胰岛素/胰高血糖素样肽-1受体激动剂组合疗法
2. Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy [J] . Shubrook Jay H. The Journal of family practice . 2018,第8Suppla期

机译：2型糖尿病进展：专注于基础胰岛素/胰高血糖素样肽-1受体激动剂组合疗法
3. Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy [J] . Jendle Johan, Testa Marcia A., Martin Sherry, Diabetes, obesity & metabolism . 2016,第10期

机译：胰高血糖素样肽-1受体激动剂dulaglutide与餐前胰岛素lispro联合治疗的2型糖尿病患者的持续血糖监测：一项AWARD-4子研究
4. Comparing artificial pancreas controlled by hybrid "closed-loop" machine learning (ML) trained algorithm to multi-daily injection (MDI), insulin pump without CGM and "sensor assisted" insulin pump therapies for Diabetes Type 1 (DT1) treatment [C] . Joan Carles Peiró International Conference on Data Analytics for Business and Industry: Way Towards a Sustainable Economy . 2020

机译：将通过混合“闭环”机器学习（ML）控制的人工胰腺培训算法对多日注于多日注射（MDI），胰岛素泵而没有CGM和“传感器辅助”胰岛素泵疗法1型（DT1）处理
5. Combinatorial targeting of the glucagon-like peptide-1 and sulfonylurea-1 receptors using a complimentary mulitvalent glucagon-like peptide-1/glibenclamide ligand for the improvement of beta-cell targeting agents and diabetic treatment. [D] . Hart, Nathaniel. 2013

机译：使用互补的多价胰高血糖素样肽-1 /格列苯脲酰胺配体对胰高血糖素样肽-1和磺酰脲-1受体进行联合靶向，以改善β细胞靶向剂和糖尿病治疗。
6. Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One? [O] . Vanita R. Aroda, Joseph R. Arulandu, Anthony J. Cannon 2018

机译：胰岛素/胰高血糖素样肽-1受体激动剂联合疗法治疗2型糖尿病：两种药物比一种更好吗？
7. The Future of Combination Therapies of Insulin with a Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes – Is it Advantageous? [O] . Baptist Gallwitz 2014

机译：胰岛素与胰高血糖素的肽-1受体激动剂在2型糖尿病中的未来 - 是有利的吗？

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?

著录项

引文网络

相似文献

相关主题

期刊订阅